6. Advances in droplet-based microfluidics for single-cell analysis Droplet-based single
Droplet-based single cell analysis systems provide an invaluable tool to accelerate research and development.
Cover image: A petri dish with bacteria under a microscope, highlighted in green, the close-up. Do the science of the future in the laboratory.
9. Mass spectrometry and proteomics: leading the charge in drug development
IPT talks to Oliver Rinner of Biognosys about Bruker’s recent majority investment, and how this, along with its own existing practices, will affect the future of proteomics research
12. High-throughput targeted metabolomics: the next generation
Metabolomics is a rapidly growing field that has the potential to revolutionise our understanding of biological systems and disease mechanisms
Discovery and Development
16. Have we found a way to help non-coders understand complex biomedical data structure?
An exploration of the thoughts on the significance of generative AI within life sciences and pharma
18. Advanced LIMS: improving pharma lab processes for a competitive edge What does Pharma
What does Pharma 4.0 look like, and how does it play a strategic role in discovery and development?
22. The growth of AI in the pharma landscape
IPT talks to Robert Strzelecki at TenderHut Group about the development of AI in the pharma industry and how its implementation will grow the sector
32. The future is bright for the connected pharma QC Lab of the Future
Could the Cloud be the catalyst many pharma QC labs need in their race to the lab of the future?
35. Using AI to accelerate biotech product development
AI is impacting biotechnology, already playing a prominent role in everything from drug and vaccine development to providing global food security
38. Natoli Engineering, an industry leader in tablet and encapsulation success
Natoli Engineering has made significant contributions to the pharmaceutical and nutraceutical industries. Natoli has advanced manufacturing technologies and practices worldwide
42. The microneedle’s edge: growth and opportunity in emerging technology
The COVID-19 pandemic has accelerated the drug-device combination product process, bringing in more outside investment and a broader range of organisations in active development
46. Integrated development strategies for drug product optimisation
What are some cheaper and time-saving alternative pathways to reformulation available to development teams?
50. mRNA therapeutics: developing and manufacturing trends in a rapidly evolving space
What are some trends in the mRNA space surrounding the growing desire for speed-to-market, and what hurdles, such as funding, are impeding the achievement of this goal?
54. Lab automation: the future of life sciences
The Module Type Package Suite from COPA-DATA ensures shorter innovation cycles and increasing demand for small batch production, meeting modern manufacturing needs
56. Automation holds the key to unlocking the Lab of the Future
The increased usage of hardware and software automation has reduced repetitive manual tasks and drastically increased the walkaway time involved in experiments
25. mmc2023 Supplement
IPT looks back on mmc’s 2023 event, including a forward from Owen Morton, publications co-ordinator for the RMS
5. Editorial Desk
As the seasons change and autumn takes hold, the future of pharmatech is also changing.
IPT looks forward to some exciting and insightful events in the upcoming months
Index of Advertisers
Natoli Engineering Company Inc.
PMGroup Worldwide Ltd
GROUP MANAGING EDITOR
PMGroup Worldwide Ltd
Daria da Silva
Tel: +44 (0)20 7724 3456
Fax: +44 (0)20 7403 7747
Hardings Print Solutions
SUBSCRIPTIONS AND DATA
Curwood CMS Ltd
Unit 9 Barns & Stables,
Tel: 01580 883841
Innovations in Pharmaceutical Technology (ISSN: 1471-7204, USPS No: 025082) is published four times a year – March, June, September, and December – by Samedan Ltd.
The opinions and views expressed by the authors in this book are not necessarily those of the Editor the Publisher and, while every care has been taken in the preparation of the book, the Editor and the Publisher are not responsible for such opinions and views or for
any inaccuracies in the articles.
The Publisher is not responsible for any images supplied by contributors. While every care is taken with artwork supplied, the Publisher cannot be held responsible for any loss or damage incurred.
The entire content of this publication is protected by copyright. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form, by any means – electronic,
mechanical, photocopying, or otherwise – without the prior permission of the Publisher.
© 2023 Samedan Ltd
Be sure to read our other publications...